ICCM vs. AMIX, HSAQ, LUCD, CTSO, NSPR, PDEX, APYX, SRTS, MGRM, and DRIO
Should you be buying IceCure Medical stock or one of its competitors? The main competitors of IceCure Medical include Autonomix Medical (AMIX), Health Sciences Acquisitions Co. 2 (HSAQ), Lucid Diagnostics (LUCD), Cytosorbents (CTSO), InspireMD (NSPR), Pro-Dex (PDEX), Apyx Medical (APYX), Sensus Healthcare (SRTS), Monogram Orthopaedics (MGRM), and DarioHealth (DRIO). These companies are all part of the "surgical & medical instruments" industry.
IceCure Medical (NASDAQ:ICCM) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, community ranking, profitability, dividends and earnings.
IceCure Medical presently has a consensus price target of $2.95, suggesting a potential upside of 145.83%. Given IceCure Medical's higher possible upside, research analysts clearly believe IceCure Medical is more favorable than Autonomix Medical.
Autonomix Medical has lower revenue, but higher earnings than IceCure Medical.
Autonomix Medical has a net margin of 0.00% compared to IceCure Medical's net margin of -453.76%. Autonomix Medical's return on equity of 0.00% beat IceCure Medical's return on equity.
IceCure Medical received 17 more outperform votes than Autonomix Medical when rated by MarketBeat users.
In the previous week, IceCure Medical and IceCure Medical both had 3 articles in the media. Autonomix Medical's average media sentiment score of 1.25 beat IceCure Medical's score of 0.91 indicating that Autonomix Medical is being referred to more favorably in the news media.
0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
Autonomix Medical beats IceCure Medical on 6 of the 11 factors compared between the two stocks.
Get IceCure Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ICCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
IceCure Medical Competitors List
Related Companies and Tools
